{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:10:26Z","timestamp":1789477826940,"version":"build-2803163510"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41386-025-02257-2","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:03:38Z","timestamp":1760119418000},"page":"373-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The nosology of addiction as a medical condition: a concise history and review of contemporary perspectives"],"prefix":"10.1038","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4595-6017","authenticated-orcid":false,"given":"Molly L.","family":"Garber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4118-9500","authenticated-orcid":false,"given":"James","family":"MacKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"2257_CR1","doi-asserted-by":"crossref","unstructured":"Szasz TS. The myth of mental illness. Am Psychol. 1960;15:113\u20138.","DOI":"10.1037\/h0046535"},{"key":"2257_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-clinpsy-032814-112800","volume":"12","author":"JC Wakefield","year":"2016","unstructured":"Wakefield JC. Diagnostic issues and controversies in DSM-5: return of the false positives problem. Annu Rev Clin Psychol. 2016;12:105\u201332.","journal-title":"Annu Rev Clin Psychol"},{"key":"2257_CR3","doi-asserted-by":"crossref","unstructured":"Leshner AI. Addiction is a brain disease, and it matters. Science. 1997;45\u20137. www.sciencemag.org.","DOI":"10.1126\/science.278.5335.45"},{"key":"2257_CR4","doi-asserted-by":"crossref","unstructured":"Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. 2021;46:1715\u201323.","DOI":"10.1038\/s41386-020-00950-y"},{"key":"2257_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/16066359.2014.987760","volume":"23","author":"TK Wiens","year":"2015","unstructured":"Wiens TK, Walker LJ. The chronic disease concept of addiction: Helpful or harmful?. Addictn Res Theory. 2015;23:309\u201321.","journal-title":"Addictn Res Theory"},{"key":"2257_CR6","doi-asserted-by":"crossref","unstructured":"Peele S. People control their addictions: no matter how much the \u201cchronic\u201d brain disease model of addiction indicates otherwise, we know that people can quit addictions \u2013 with special reference to harm reduction and mindfulness. Addictn Behav Rep. 2016;4:97\u2013101. https:\/\/w-ww.sciencedirect.com\/science\/article\/pii\/S235285321630013X?via%3Dihub.","DOI":"10.1016\/j.abrep.2016.05.003"},{"key":"2257_CR7","doi-asserted-by":"crossref","unstructured":"Field M, Heather N, Wiers RW. Indeed, not really a brain disorder: implications for reductionist accounts of addiction. Behav Brain Sci. 2019;42.","DOI":"10.1017\/S0140525X18001024"},{"key":"2257_CR8","doi-asserted-by":"crossref","unstructured":"Cunningham JA. Addiction: many factors contribute. Nature. 2014;507:40. https:\/\/www.nature.com\/articles\/507040d.","DOI":"10.1038\/507040d"},{"key":"2257_CR9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/add.12553","volume":"109","author":"J Brown","year":"2014","unstructured":"Brown J, Michie S, Raupach T, West R. Animal Farm must give way to doublethink when studying addiction. Addiction. 2014;109:1214\u20135. https:\/\/doi.org\/10.1111\/add.12553.","journal-title":"Addiction"},{"key":"2257_CR10","doi-asserted-by":"crossref","unstructured":"Heim D. Addiction: not just brain malfunction. Nature. 2014;507:40. http:\/\/www.nature.com\/articles\/507040e.","DOI":"10.1038\/507040e"},{"key":"2257_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1108\/S1057-6290(2012)0000014006","volume":"14","author":"K Kaye","year":"2012","unstructured":"Kaye K. De-Medicalizing addiction: Toward biocultural understandings. Adv Med Socio. 2012;14:27\u201351.","journal-title":"Adv Med Socio"},{"key":"2257_CR12","unstructured":"Suissa AJ. Medicalization and addictions: Markers and Psychosocial Issues. Canadian Social Work Review \/ Revue Canadienne de Service Social. 2009;26:43\u201358. http:\/\/www.jstor.org\/stable\/41669901."},{"key":"2257_CR13","doi-asserted-by":"crossref","unstructured":"Chau LW, Erickson M, Vigo D, Lou H, Pakhomova T, Winston ML, et al. The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders. Int J Drug Policy. 2021;97:103208. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0955395921001067.","DOI":"10.1016\/j.drugpo.2021.103208"},{"key":"2257_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/10826084.2017.1310247","volume":"53","author":"D Frank","year":"2018","unstructured":"Frank D. I was not sick and i didn\u2019t need to recover\u201d: methadone maintenance treatment (MMT) as a refuge from criminalization. Subst Use Misuse. 2018;53:311\u201322. https:\/\/doi.org\/10.1080\/10826084.2017.1310247.","journal-title":"Subst Use Misuse"},{"key":"2257_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s44159-023-00167-y","volume":"2","author":"SF Acuff","year":"2023","unstructured":"Acuff SF, MacKillop J, Murphy JG. A contextualized reinforcer pathology approach to addiction. Nat Rev Psychol. 2023;2:309\u201323. https:\/\/www.nature.com\/articles\/s44159-023-00167-y.","journal-title":"Nat Rev Psychol"},{"key":"2257_CR16","doi-asserted-by":"publisher","unstructured":"Witkiewitz K, Tucker JA. Whole person recovery from substance use disorder: a call for research examining a dynamic behavioral ecological model of contexts supportive of recovery. Addictn Res Theory. 2024 https:\/\/doi.org\/10.1080\/16066359.2024.2329580.","DOI":"10.1080\/16066359.2024.2329580"},{"key":"2257_CR17","doi-asserted-by":"crossref","unstructured":"Rosenthal RJ, Faris SB. The etymology and early history of \u2018addiction. Addictn Res Theory. 2019;27:437\u201349.","DOI":"10.1080\/16066359.2018.1543412"},{"key":"2257_CR18","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders 5. American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2257_CR19","unstructured":"World Health Organization. International Classification of Diseases. 2019."},{"key":"2257_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2105\/AJPH.83.2.273","volume":"83","author":"BS Katcher","year":"1993","unstructured":"Katcher BS. Benjamin Rush\u2019s educational campaign against hard drinking. Am J Public Health. 1993;83:273. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1694575\/.","journal-title":"Am J Public Health"},{"key":"2257_CR21","unstructured":"Institute of Medicine (US) Committee on Opportunities in Drug Abuse Research. Pathways of Addiction: Opportunities in Drug Abuse Research. Washington (DC): National Academies Press (US); 1996. B, Drug Abuse Research in Historical Perspective. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK232965\/"},{"key":"2257_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1360-0443.1996.91112114.x","volume":"91","author":"FW Kielhorn","year":"1996","unstructured":"Kielhorn FW. The history of alcoholism: Br\u00fchl-Cramer\u2019s concepts and observations. Addiction. 1996;91:121\u20138. https:\/\/doi.org\/10.1046\/j.1360-0443.1996.91112114.x.","journal-title":"Addiction"},{"key":"2257_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.31887\/DCNS.2007.9.4\/macrocq","volume":"9","author":"MA Crocq","year":"2007","unstructured":"Crocq MA. Historical and cultural aspects of man\u2019s relationship with addictive drugs. Dialogues Clin Neurosci. 2007;9:355. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3202501\/.","journal-title":"Dialogues Clin Neurosci"},{"key":"2257_CR24","unstructured":"White WL. Slaying the dragon: the history of addiction treatment and recovery in America. In: Slaying the dragon: the history of addiction treatment and recovery in America. 2nd ed. Chestnut Health Systems; 1998 https:\/\/archive.org\/details\/slayingdragonhis00whit\/page\/22\/mode\/2up?view=theater."},{"key":"2257_CR25","unstructured":"Office of the Surgeon General ASForces. Nomenclature of psychiatric disorders and reactions. War Department Technical Bulletin, Medical 203;1946. https:\/\/pubmed.ncbi.nlm.nih.gov\/10902951\/."},{"key":"2257_CR26","doi-asserted-by":"publisher","unstructured":"Statistical Manual for the Use of Institutions for the Insane. (New York: The National Committee for Mental Hygiene, Bureau of Statistics, 1918.). Am J Psychiatry. 1918;75:301. https:\/\/doi.org\/10.1176\/ajp.75.2.301.","DOI":"10.1176\/ajp.75.2.301"},{"key":"2257_CR27","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1176\/ajp.126.7.983","volume":"126","author":"E Robins","year":"1970","unstructured":"Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126:983\u20137.","journal-title":"Am J Psychiatry"},{"key":"2257_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","volume":"26","author":"JP Feighner","year":"1972","unstructured":"Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26:57\u201363. http:\/\/archpsyc.jamanetwork.com\/.","journal-title":"Arch Gen Psychiatry"},{"key":"2257_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1136\/bmj.1.6017.1058","volume":"1","author":"G Edwards","year":"1976","unstructured":"Edwards G, Gross MM. Alcohol dependence: provisional description of a clinical syndrome. Br Med J. 1976;1:1058\u201361. https:\/\/about.jstor.org\/terms.","journal-title":"Br Med J"},{"key":"2257_CR30","unstructured":"Moriyama IM, Loy RM, Robb-Smith AHT, Rosenberg HM, Hoyert DL, National Center for Health Statistics (U.S.). History of the statistical classification of diseases and causes of death. 2011. CDC National Centre for Health Statistics"},{"key":"2257_CR31","unstructured":"Hird TA. The morphia habit [Edinburgh]. University of Edinburgh; 1882."},{"key":"2257_CR32","unstructured":"Bertillon J. International classification of causes of sickness and death. Palo Alto; 1909 https:\/\/books.google.ca\/books?id=iBR9entwjg0C&newbks=1&newbks_redir=0&dq=bertillon+classification&pg=PA1&redir_esc=y#v=onepage&q&f=false."},{"key":"2257_CR33","unstructured":"American Public Health Association & Conference Of State And Provincial Boards Of Health Of North America. The Bertillon classification of causes of death. [Lansing Mich. R. Smith print. co](1899) Library of Congress, https:\/\/www.loc.gov\/item\/01005126\/."},{"key":"2257_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1360-0443.1932.tb04842.x","volume":"29","author":"WN East","year":"1932","unstructured":"East WN. Mental defectiveness and alcohol and drug addiction. Br J Inebr. 1932;29:149\u201366.","journal-title":"Br J Inebr"},{"key":"2257_CR35","unstructured":"Chopra RN, Bose JP. Psychological aspects of opium addiction. Ind Med Gaz. 1931;663\u20136."},{"key":"2257_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1086\/217773","volume":"43","author":"AR Lindesmith","year":"1938","unstructured":"Lindesmith AR. A sociological theory of drug addiction. Am J Sociol. 1938;43:593\u2013613. https:\/\/www.jstor.org\/stable\/2768486.","journal-title":"Am J Sociol"},{"key":"2257_CR37","doi-asserted-by":"crossref","unstructured":"Hart B. Discussion on the aetiology of alcoholism. Proceedings of the Royal Society of Medicine. 1928;21:1341\u201360.","DOI":"10.1177\/003591572802100815"},{"key":"2257_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1192\/bjp.125.4.341","volume":"123","author":"RL Spitzer","year":"1974","unstructured":"Spitzer RL, Fleiss JL. A re-analysis of the reliability of psychiatric diagnosis. Br J Psychiatry. 1974;123:341\u20137.","journal-title":"Br J Psychiatry"},{"key":"2257_CR39","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 1952. Washington, DC: Author"},{"key":"2257_CR40","doi-asserted-by":"crossref","unstructured":"Lassiter PS, Culbreth JR. Historical perspectives and the moral model: theory and practice of addiction counseling. In: Theory and practice of addiction counseling. SAGE Publications, Inc.; 2018. p. 27\u201346.","DOI":"10.4135\/9781071800461.n5"},{"key":"2257_CR41","doi-asserted-by":"crossref","unstructured":"Juchem CM, Bendau A, Bandurski LC, Reich NJ, Baumgardt S, Asselmann E. Personality changes related to presence and treatment of substance use (disorders): a systematic review. Psychol Med. 2024;54:1905\u201329. https:\/\/www.cambridge.org\/core\/journals\/psychological-medicine\/article\/personality-changes-related-to-presence-and-treatment-of-substance-use-disorders-a-systematic-review\/A3674BD132B366F0101C536EB053DE20.","DOI":"10.1017\/S003329172400093X"},{"key":"2257_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1037\/bul0000088","volume":"143","author":"BW Roberts","year":"2017","unstructured":"Roberts BW, Luo J, Briley DA, Chow PI, Su R, Hill PL. A systematic review of personality trait change through intervention. Psychol Bull. 2017;143:117\u201341. https:\/\/pubmed.ncbi.nlm.nih.gov\/28054797\/.","journal-title":"Psychol Bull"},{"key":"2257_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1037\/a0020327","volume":"136","author":"R Kotov","year":"2010","unstructured":"Kotov R, Gamez W, Schmidt F, Watson D. Linking \u201cBig\u201d personality traits to anxiety, depressive, and substance use disorders: a meta-analysis. Psychol Bull. 2010;136:768\u2013821. https:\/\/pubmed.ncbi.nlm.nih.gov\/20804236\/.","journal-title":"Psychol Bull"},{"key":"2257_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/j.2051-5545.2009.tb00197.x","volume":"8","author":"RF Krueger","year":"2009","unstructured":"Krueger RF, Bezdjian S. Enhancing research and treatment of mental disorders with dimensional concepts: toward DSM-V and ICD-11. World Psychiatry. 2009;8:3\u20136.","journal-title":"World Psychiatry"},{"key":"2257_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1176\/appi.ajp.2012.12070999","volume":"170","author":"DA Regier","year":"2013","unstructured":"Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, et al. DSM-5 field trials in the United States and Canada, part II: Test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170:59\u201370. https:\/\/doi.org\/10.1176\/appi.ajp.2012.12070999.","journal-title":"Am J Psychiatry"},{"key":"2257_CR46","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders fifth edition text revision. 5th-TR ed. APA; 2022."},{"key":"2257_CR47","doi-asserted-by":"crossref","unstructured":"Mayes R, Horwitz AV. DSM-III and the revolution in the classification of mental illness. J Hist Behav Sci. 2005;41:249\u201367.","DOI":"10.1002\/jhbs.20103"},{"key":"2257_CR48","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders III-R. 1987. Washington D.C. (Author)"},{"key":"2257_CR49","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1176\/ajp.2006.163.5.764","volume":"163","author":"CP O\u2019Brien","year":"2006","unstructured":"O\u2019Brien CP, Volkow N, Li TK. What\u2019s in a word? Addiction versus dependence in DSM-V. Am J Psychiatry. 2006;163:764\u20135.","journal-title":"Am J Psychiatry"},{"key":"2257_CR50","doi-asserted-by":"crossref","unstructured":"Hasin DS, O\u2019Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: Recommendations and rationale. Am J Psychiatry. 2013;170:834\u201351.","DOI":"10.1176\/appi.ajp.2013.12060782"},{"key":"2257_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/wps.20825","volume":"20","author":"MB First","year":"2021","unstructured":"First MB, Gaebel W, Maj M, Stein DJ, Kogan CS, Saunders JB, et al. An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5. World Psychiatry. 2021;20:34\u201351. https:\/\/doi.org\/10.1002\/wps.20825.","journal-title":"World Psychiatry"},{"key":"2257_CR52","unstructured":"Reed GM, First MB, Kogan CS, Hyman SE, Gureje O, Gaebel W, et al. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry. 2019;18:3. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6313247\/."},{"key":"2257_CR53","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jpsychires.2022.09.016","volume":"155","author":"DS Fink","year":"2022","unstructured":"Fink DS, Shmulewitz D, Mannes ZL, Stohl M, Livne O, Wall M, et al. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use. J Psychiatr Res. 2022;155:387\u201394.","journal-title":"J Psychiatr Res"},{"key":"2257_CR54","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/j.2051-5545.2011.tb00034.x","volume":"10","author":"GM Reed","year":"2011","unstructured":"Reed GM, Correia JM, Esparza P, Saxena S, Maj M. The WPA-WHO Global Survey of Psychiatrists\u2019 attitudes towards mental disorders classification. World Psychiatry. 2011;10:118. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3105474\/.","journal-title":"World Psychiatry"},{"key":"2257_CR55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10802-010-9478-y","volume":"39","author":"KE Walton","year":"2011","unstructured":"Walton KE, Ormel J, Krueger RF. The dimensional nature of externalizing behaviors in adolescence: evidence from a direct comparison of categorical, dimensional, and hybrid models. J Abnorm Child Psychol. 2011;39:553\u201361.","journal-title":"J Abnorm Child Psychol"},{"key":"2257_CR56","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1017\/S0033291711001966","volume":"42","author":"N Haslam","year":"2012","unstructured":"Haslam N, Holland E, Kuppens P. Categories versus dimensions in personality and psychopathology: a quantitative review of taxometric research. Psychol Med. 2012;42:903\u201320.","journal-title":"Psychol Med"},{"key":"2257_CR57","doi-asserted-by":"crossref","unstructured":"Garber ML, Taisir R, Costello J, MacKillop J. Taxonicity of cannabis use disorder: findings from a large community sample and an inpatient clinical sample. J Psychopathol Clin Sci. 2025;134:790\u20138.","DOI":"10.1037\/abn0001031"},{"key":"2257_CR58","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1017\/S0033291711000717","volume":"41","author":"CS Martin","year":"2011","unstructured":"Martin CS, Steinley DL, Verg\u00e9s A, Sher KJ. Letter to the Editor: The proposed 2\/11 symptom algorithm for DSM-5 substance-use disorders is too lenient. Psychol Med. 2011;41:2008\u201310.","journal-title":"Psychol Med"},{"key":"2257_CR59","doi-asserted-by":"publisher","unstructured":"Mcqueen J, Howe TE, Allan L, Mains D, Hardy V. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev. 2011;2011. https:\/\/doi.org\/10.1002\/14651858.CD005191.pub3\/full.","DOI":"10.1002\/14651858.CD005191.pub3\/full"},{"key":"2257_CR60","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11606-006-5063-z12:5","volume":"12","author":"AI Wilk","year":"1997","unstructured":"Wilk AI, Jensen NM, Havighurst TC. Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. J Gen Intern Med. 1997;12:274\u201383. https:\/\/doi.org\/10.1007\/s11606-006-5063-z12:5.","journal-title":"J Gen Intern Med"},{"key":"2257_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1037\/0021-843X.110.4.585","volume":"110","author":"TA Brown","year":"2001","unstructured":"Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001;110:585\u201399.","journal-title":"J Abnorm Psychol"},{"key":"2257_CR62","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Tat Chiu W, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:617\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"2257_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.wpsyc.2012.01.004","volume":"11","author":"D Westen","year":"2012","unstructured":"Westen D. Prototype diagnosis of psychiatric syndromes. World Psychiatry. 2012;11:16\u201321.","journal-title":"World Psychiatry"},{"key":"2257_CR64","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1037\/adb0000723","volume":"35","author":"A Verg\u00e9s","year":"2021","unstructured":"Verg\u00e9s A, Lee MR, Martin CS, Trull TJ, Martens MP, Wood PK, et al. Not all symptoms of alcohol dependence are developmentally equivalent: implications for the false-positives problem. Psychol Addic. Behav. 2021;35:444\u201357.","journal-title":"Psychol Addic. Behav"},{"key":"2257_CR65","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1037\/h0056029","volume":"55","author":"K Maccorquodale","year":"1948","unstructured":"Maccorquodale K, Meehl PE. On a distinction between hypothetical constructs and intervening variables. Psychol Rev. 1948;55:95\u2013107.","journal-title":"Psychol Rev"},{"key":"2257_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/jamapsychiatry.2013.270","volume":"70","author":"JA DeFife","year":"2013","unstructured":"DeFife JA, Peart J, Bradley B, Ressler K, Drill R, Westen D. Validity of prototype diagnosis for mood and anxiety disorders. JAMA Psychiatry. 2013;70:140\u20138.","journal-title":"JAMA Psychiatry"},{"key":"2257_CR67","doi-asserted-by":"crossref","unstructured":"Westen D, Shedler J, Bradley R. A prototype approach to personality disorder diagnosis. Am J Psychiatry. 2006;163:846\u201356.","DOI":"10.1176\/ajp.2006.163.5.846"},{"key":"2257_CR68","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1037\/abn0000258","volume":"126","author":"R Kotov","year":"2017","unstructured":"Kotov R, Waszczuk MA, Krueger RF, Forbes MK, Watson D, Clark LA, et al. The hierarchical taxonomy of psychopathology (HiTOP): a dimensional alternative to traditional nosologies. J Abnorm Psychol. 2017;126:454\u201377.","journal-title":"J Abnorm Psychol"},{"key":"2257_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-clinpsy-081219-","volume":"17","author":"R Kotov","year":"2021","unstructured":"Kotov R, Krueger RF, Watson D, Cicero DC, Conway CC, Deyoung CG, et al. The Hierarchical Taxonomy of Psychopathology (HiTOP): a quantitative nosology based on consensus of evidence. Annu Rev Clin Psychol. 2021;17:83\u2013108. https:\/\/doi.org\/10.1146\/annurev-clinpsy-081219-.","journal-title":"Annu Rev Clin Psychol"},{"key":"2257_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/wps.20772","volume":"19","author":"ID Waldman","year":"2020","unstructured":"Waldman ID, Poore HE, Luningham JM, Yang J. Testing structural models of psychopathology at the genomic level. World Psychiatry. 2020;19:350\u20139.","journal-title":"World Psychiatry"},{"key":"2257_CR71","first-page":"533","volume":"53","author":"WR Ringwald","year":"2021","unstructured":"Ringwald WR, Forbes MK, Wright AGC. Meta-analysis of structural evidence for the Hierarchical Taxonomy of Psychopathology (HiTOP) model. Psychol Med. 2021;53:533\u201346.","journal-title":"Psychol Med"},{"key":"2257_CR72","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/21677026211068873","volume":"10","author":"GJ Haeffel","year":"2022","unstructured":"Haeffel GJ, Jeronimus BF, Fisher AJ, Kaiser BN, Weaver LJ, Vargas I, et al. The Hierarchical Taxonomy of Psychopathology (HiTOP) is not an improvement over the DSM. Clin Psychol Sci. 2022;10:285\u201390.","journal-title":"Clin Psychol Sci"},{"key":"2257_CR73","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","volume":"167","author":"T Insel","year":"2010","unstructured":"Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748\u201351.","journal-title":"Am J Psychiatry"},{"key":"2257_CR74","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1037\/a0020909","volume":"119","author":"CA Sanislow","year":"2010","unstructured":"Sanislow CA, Pine DS, Quinn KJ, Kozak MJ, Garvey MA, Heinssen RK, et al. Developing constructs for psychopathology research: research domain criteria. J Abnorm Psychol. 2010;119:631\u20139.","journal-title":"J Abnorm Psychol"},{"key":"2257_CR75","doi-asserted-by":"crossref","unstructured":"Lempert KM, Steinglass JE, Pinto A, Kable JW, Simpson HB. Can delay discounting deliver on the promise of RDoC? Psychol Med. 2019;49:190\u20139.","DOI":"10.1017\/S0033291718001770"},{"key":"2257_CR76","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neuroimage.2017.08.045","volume":"161","author":"MM Owens","year":"2017","unstructured":"Owens MM, Gray JC, Amlung MT, Oshri A, Sweet LH, MacKillop J. Neuroanatomical foundations of delayed reward discounting decision making. NeuroImage. 2017;161:261\u201370.","journal-title":"NeuroImage"},{"key":"2257_CR77","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1037\/bul0000181","volume":"145","author":"MM Owens","year":"2019","unstructured":"Owens MM, Syan SK, Amlung M, Beach SRH, Sweet LH, MacKillop J. Functional and structural neuroimaging studies of delayed reward discounting in addiction: a systematic review. Psychol Bull. 2019;145:141\u201364.","journal-title":"Psychol Bull"},{"key":"2257_CR78","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41593-017-0032-x","volume":"21","author":"S Sanchez-Roige","year":"2018","unstructured":"Sanchez-Roige S, Fontanillas P, Elson SL, Pandit A, Schmidt EM, Foerster JR, et al. Genome-wide association study of delay discounting in 23,217 adult research participants of European ancestry. Nat Neurosci. 2018;21:16\u201320.","journal-title":"Nat Neurosci"},{"key":"2257_CR79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00213-011-2229-0","volume":"216","author":"J MacKillop","year":"2011","unstructured":"MacKillop J, Amlung MT, Few LR, Ray LA, Sweet LH, Munaf\u00f2 MR. Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology. 2011;216:305\u201321.","journal-title":"Psychopharmacology"},{"key":"2257_CR80","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/jamapsychiatry.2019.2102","volume":"76","author":"M Amlung","year":"2019","unstructured":"Amlung M, Marsden E, Holshausen K, Morris V, Patel H, Vedelago L, et al. Delay discounting as a transdiagnostic process in psychiatric disorders: a meta-analysis. JAMA Psychiatry. 2019;76:1176\u201386.","journal-title":"JAMA Psychiatry"},{"key":"2257_CR81","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bpsc.2016.01.007","volume":"1","author":"JNS Jackson","year":"2016","unstructured":"Jackson JNS, Mackillop J. Attention-deficit hyperactivity disorder and monetary delay discounting: a meta-analysis of case-control studies. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1:316\u201325. https:\/\/doi.org\/10.1016\/j.bpsc.2016.01.007.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2257_CR82","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/da.22586","volume":"34","author":"JE Steinglass","year":"2016","unstructured":"Steinglass JE, Lempert KM, Choo TH, Kimeldorf MB, Wall M, Walsh BT, et al. Temporal discounting across three psychiatric disorders: anorexia nervosa, obsessive compulsive disorder, and social anxiety disorder. Depress Anxiety. 2016;34:463\u201370.","journal-title":"Depress Anxiety"},{"key":"2257_CR83","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brat.2014.07.019","volume":"62","author":"SO Lilienfeld","year":"2014","unstructured":"Lilienfeld SO. The Research Domain Criteria (RDoC): an analysis of methodological and conceptual challenges. Behav Res Ther. 2014;62:129\u201339.","journal-title":"Behav Res Ther"},{"key":"2257_CR84","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biopsych.2015.10.024","volume":"80","author":"LE Kwako","year":"2016","unstructured":"Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry. 2016;80:179\u201389.","journal-title":"Biol Psychiatry"},{"key":"2257_CR85","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/acer.14283","volume":"44","author":"VR Votaw","year":"2020","unstructured":"Votaw VR, Pearson MR, Stein E, Witkiewitz K. The addictions neuroclinical assessment negative emotionality domain among treatment-seekers with alcohol use disorder: construct validity and measurement invariance. Alcohol Clin Exp Res. 2020;44:679\u201388.","journal-title":"Alcohol Clin Exp Res"},{"key":"2257_CR86","doi-asserted-by":"crossref","unstructured":"Votaw VR, Boness CL, Stein ER, Watts AL, Sher KJ, Witkiewitz K. Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use. Exp Clin Psychopharmacol. 2023;32:68\u201383.","DOI":"10.1037\/pha0000648"},{"key":"2257_CR87","doi-asserted-by":"crossref","unstructured":"Nieto SJ, Ray LA. Applying the addictions neuroclinical assessment to derive neurofunctional domains in individuals who use methamphetamine. Behav Brain Res. 2022;427:113876.","DOI":"10.1016\/j.bbr.2022.113876"},{"key":"2257_CR88","doi-asserted-by":"crossref","unstructured":"Nieto SJ, Grodin EN, Green RJ, Ray LA. Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers. Drug Alcohol Depend. 2021;221.","DOI":"10.1016\/j.drugalcdep.2021.108603"},{"key":"2257_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-024-02987-9","volume":"14","author":"T Gunawan","year":"2024","unstructured":"Gunawan T, Luk JW, Schwandt ML, Kwako LE, Vinson T, Horneffer Y, et al. Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery. Transl Psychiatry. 2024;14:1\u201312. http:\/\/www.nature.com\/articles\/s41398-024-02987-9.","journal-title":"Transl Psychiatry"},{"key":"2257_CR90","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.addbeh.2015.07.009","volume":"51","author":"MK Meisel","year":"2015","unstructured":"Meisel MK, Clifton AD, MacKillop J, Goodie AS. A social network analysis approach to alcohol use and co-occurring addictive behavior in young adults. Addictive Behav. 2015;51:72\u20139. http:\/\/pubmed.ncbi.nlm.nih.gov\/26240940\/.","journal-title":"Addictive Behav"},{"key":"2257_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108713","volume":"137","author":"O Falade-Nwulia","year":"2021","unstructured":"Falade-Nwulia O, Felsher M, Kidorf M, Tobin K, Yang C, Latkin C. The impact of social network dynamics on engagement in drug use reduction programs among men and women who use drugs. J Subst Abus Treat. 2021;137. 108713. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9086095\/.","journal-title":"J Subst Abus Treat"},{"key":"2257_CR92","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1056\/NEJMsa0706154","volume":"358","author":"NA Christakis","year":"2008","unstructured":"Christakis NA, Fowler JH. The collective dynamics of smoking in a large social network. N Engl J Med. 2008;358:2249\u201358. http:\/\/pubmed.ncbi.nlm.nih.gov\/18499567\/.","journal-title":"N Engl J Med"},{"key":"2257_CR93","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/acer.14351","volume":"44","author":"SF Acuff","year":"2020","unstructured":"Acuff SF, MacKillop J, Murphy JG. Integrating behavioral economic and social network influences in understanding alcohol misuse in a diverse sample of emerging adults. Alcohol Clin Exp Res. 2020;44:1444\u201355. https:\/\/doi.org\/10.1111\/acer.14351.","journal-title":"Alcohol Clin Exp Res"},{"key":"2257_CR94","doi-asserted-by":"crossref","unstructured":"Levitt EE, Singh D, Clifton A, Stout R, Sweet L, Kelly JF, et al. Diagnostic discrimination of social network indicators in alcohol use disorder: initial examination using high-resolution and brief assessments. Psychol Addict Behav. 2024;38. https:\/\/pubmed.ncbi.nlm.nih.gov\/38635199\/.","DOI":"10.1037\/adb0001006"},{"key":"2257_CR95","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/alcalc\/agt127","volume":"48","author":"J Rehm","year":"2013","unstructured":"Rehm J, Marmet S, Anderson P, Gual A, Kraus L, Nutt DJ, et al. Defining substance use disorders: Dowe really need more than heavy use?. Alcohol Alcohol. 2013;48:633\u201340.","journal-title":"Alcohol Alcohol"},{"key":"2257_CR96","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/alcalc\/agt132","volume":"48","author":"KA Bradley","year":"2013","unstructured":"Bradley KA, Rubinsky AD. Why not add consumption measures to current definitions of substance use disorders? Commentary on rehm et al. \u201cdefining substance use disorders: Dowe really need more than heavy use?. Alcohol Alcohol. 2013;48:642\u20133.","journal-title":"Alcohol Alcohol"},{"key":"2257_CR97","doi-asserted-by":"crossref","unstructured":"Garber ML, Samokhvalov A, Chorny Y, LaBelle O, Rush B, Costello J, et al. Diagnostic validity of drinking behaviour for identifying alcohol use disorder: findings from a representative sample of community adults and an inpatient clinical sample. Addiction. 2025;120. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40162686.","DOI":"10.1101\/2024.09.14.24313683"},{"key":"2257_CR98","doi-asserted-by":"crossref","unstructured":"MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, et al. Hazardous drinking and alcohol use disorders. Nat Rev Dis Primers. 2022;8. https:\/\/pubmed.ncbi.nlm.nih.gov\/36550121\/.","DOI":"10.1038\/s41572-022-00406-1"},{"key":"2257_CR99","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1192\/bjp.bp.112.110858","volume":"202","author":"J Scott","year":"2013","unstructured":"Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, et al. Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry. 2013;202:243\u20135.","journal-title":"Br J Psychiatry"},{"key":"2257_CR100","doi-asserted-by":"crossref","unstructured":"Patel A, West HJ. What does my stage of cancer mean? JAMA Oncol. 2020;6:1308.","DOI":"10.1001\/jamaoncol.2020.1592"},{"key":"2257_CR101","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1586\/ern.09.31","volume":"9","author":"F Kapczinski","year":"2009","unstructured":"Kapczinski F, Dias VV, Kauer-Sant\u2019Anna M, Frey BN, Grassi-Oliveira R, Colom F, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009;9:957\u201366.","journal-title":"Expert Rev Neurother"},{"key":"2257_CR102","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamapsychiatry.2022.1652","volume":"79","author":"AT McLellan","year":"2022","unstructured":"McLellan AT, Koob GF, Volkow ND. Preaddiction\u2014a missing concept for treating substance use disorders. JAMA Psychiatry. 2022;79:749\u201351. https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2793694.","journal-title":"JAMA Psychiatry"},{"key":"2257_CR103","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41386-023-01764-4","volume":"49","author":"CL Boness","year":"2023","unstructured":"Boness CL, Kataria K, Morris J. Should we embrace the term \u2018preaddiction\u2019? Neuropsychopharmacology. 2023;49:495. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10789777\/.","journal-title":"Neuropsychopharmacology"},{"key":"2257_CR104","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJMp1917360","volume":"382","author":"ND Volkow","year":"2020","unstructured":"Volkow ND. Stigma and the toll of addiction. New Engl J Med. 2020;382:1289\u201390.","journal-title":"New Engl J Med"},{"key":"2257_CR105","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.drugpo.2009.10.010","volume":"21","author":"JF Kelly","year":"2010","unstructured":"Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21:202\u20137.","journal-title":"Int J Drug Policy"},{"key":"2257_CR106","doi-asserted-by":"crossref","unstructured":"Saitz R. International statement recommending against the use of terminology that can stigmatize people. J Addiction Med. 2016;10:1\u20132.","DOI":"10.1097\/ADM.0000000000000178"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02257-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02257-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02257-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T23:02:33Z","timestamp":1765926153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02257-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02257-2","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JM is a principal in BEAM Diagnostics, Inc. and MLG has no potential conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}